| Tommy Wayne Smith, | |
|
1305 Mcmillan Ave, Brewton, AL 36426-1324 | |
| (251) 809-3191 | |
| (251) 809-8215 |
| Full Name | Tommy Wayne Smith |
|---|---|
| Gender | Male |
| Speciality | Marriage & Family Therapist |
| Location | 1305 Mcmillan Ave, Brewton, Alabama |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1386130920 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 106H00000X | Marriage & Family Therapist | 224 (Alabama) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Tommy Wayne Smith, 1305 Mcmillan Ave, Brewton, AL 36426-1324 Ph: (251) 809-3191 | Tommy Wayne Smith, 1305 Mcmillan Ave, Brewton, AL 36426-1324 Ph: (251) 809-3191 |
News Archive
Cardio3 BioSciences, a leader in engineered cell therapies with clinical programs initially targeting indications in cardiovascular disease and oncology, today announced that it has received a Notice of Allowance from the U.S. Patent and Trademark Office for a significant patent application covering T-Cell receptor-deficient T-Cells which are engineered to express a chimeric antigen receptor.
Most children who suffer from sports-related concussions recover within a few days. However, in a small number of children, symptoms can last for a month or more. Although there have been numerous theories as to what might predict a longer recovery time, there is no definitive answer as to why it takes some children longer to recover.
Corning Incorporated today announced the launch of its HepGo™ Assay-ready 3D liver spheroid kit, the first plug-and-play solution to include 96 pre-plated primary human hepatocyte (PHH) spheroids in a single-spheroid microplate (one uniform spheroid per well) and HepGo Hepatocyte companion cell culture media.
The Austrian Breast & Colorectal Cancer Study Group, Alliance Foundation Trials, the Breast International Group, PrECOG, LLC, the German Breast Group, and the NSABP Foundation today announced that the independent Data Monitoring Committee for the global Phase 3 early breast cancer PALbociclib CoLlaborative Adjuvant Study trial determined that the study is unlikely to show a statistically significant improvement in the primary endpoint of invasive disease-free survival following a preplanned interim analysis.
NeuroVasx announced today that the FDA has approved the cPAX Aneurysm Treatment System as a Humanitarian Use Device for the treatment of large, giant and wide-neck cerebral aneurysms, which are typically the most difficult to treat. The HDE allows for the treatment of up to 4,000 patients per year in the U.S.
› Verified 6 days ago
Mrs. Melinda Denise Bondurant, LPC Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 722 Douglas Ave, Brewton, AL 36426 Phone: 334-222-1818 Fax: 334-222-1919 |